First-time prescriptions of biological diseasemodifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: Data from the NOR-DMARD register

Annals of the Rheumatic Diseases

Volumn 73, Issue 10, 2014, Pages 1905-1906

  Lie, Elisabeth ^a   Fagerli, Karen M ^a   Mikkelsen, Knut ^b   Rødevand, Erik ^c   Lexberg, Åse ^d   Kalstad, Synøve ^e   Uhlig, Till ^a   Kvien, Tore K ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b Hospital for Rheumatic Diseases   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d Drammen Hosp   (Norway)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT;

ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; DRUG UTILIZATION; HUMAN; NORWAY; PRESCRIPTION; REGISTER; SPONDYLARTHRITIS; STATISTICS AND NUMERICAL DATA; TRENDS;

ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HUMANS; NORWAY; REGISTRIES; SPONDYLARTHRITIS;

EID: 84925227455     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205490     Document Type: Letter

References (9)

1. Kvien TK, Heiberg, Lie E, et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005;23:S188-94.
2. Statistics Norway. http://www.ssb.no (accessed Jun. 2012).
3. Kvien TK, Glennas A, Knudsrod OG, et al. The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 1997;26:412-8.
4. Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 2000;27:1386-9.
5. Madland TM, Apalset EM, Johannessen AE, et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005;32:1918-22.
6. Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005;53:850-5.
7. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
8. van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-8.
9. Machado P, Landewe R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. nn Rheum Dis 2011;70:47-53.